Glucagon-Like Peptide-1 Analog, Liraglutide, Delays Onset of Experimental Autoimmune Encephalitis in Lewis Rats

Introduction: Recent findings indicate that metabolic disturbances are involved in multiple sclerosis (MS) pathology and influence the susceptibility to treatment, directing attention toward anti-diabetic drugs such as metformin and pioglitazone. Liraglutide, a drug of the glucagon-like peptide-1 (G...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Front Pharmacol
मुख्य लेखकों: DellaValle, Brian, Brix, Gitte S., Brock, Birgitte, Gejl, Michael, Landau, Anne M., Møller, Arne, Rungby, Jørgen, Larsen, Agnete
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Frontiers Media S.A. 2016
विषय:
Pharmacology
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC5114298/
https://ncbi.nlm.nih.gov/pubmed/27917122
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2016.00433
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन